119 related articles for article (PubMed ID: 12416025)
21. Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells.
Plo I; Lautier D; Levade T; Sekouri H; Jaffrézou JP; Laurent G; Bettaïeb A
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):459-67. PubMed ID: 11023832
[TBL] [Abstract][Full Text] [Related]
22. Hexadecylphosphocholine alters nonvesicular cholesterol traffic from the plasma membrane to the endoplasmic reticulum and inhibits the synthesis of sphingomyelin in HepG2 cells.
Marco C; Jiménez-López JM; Ríos-Marco P; Segovia JL; Carrasco MP
Int J Biochem Cell Biol; 2009 Jun; 41(6):1296-303. PubMed ID: 19084611
[TBL] [Abstract][Full Text] [Related]
23. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity.
Uberall F; Oberhuber H; Maly K; Zaknun J; Demuth L; Grunicke HH
Cancer Res; 1991 Feb; 51(3):807-12. PubMed ID: 1846318
[TBL] [Abstract][Full Text] [Related]
24. Hexadecylphosphocholine disrupts cholesterol homeostasis and induces the accumulation of free cholesterol in HepG2 tumour cells.
Jiménez-López JM; Carrasco MP; Marco C; Segovia JL
Biochem Pharmacol; 2006 Apr; 71(8):1114-21. PubMed ID: 16466701
[TBL] [Abstract][Full Text] [Related]
25. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
[TBL] [Abstract][Full Text] [Related]
26. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB.
Fleer EA; Berkovic D; Grunwald U; Hiddemann W
Eur J Cancer; 1996 Mar; 32A(3):506-11. PubMed ID: 8814699
[TBL] [Abstract][Full Text] [Related]
27. Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography.
Brochez V; Van Heuverswyn D; Diniz JA; De Potter CR; Van den Eeckhout EG
Lipids; 1999 May; 34(5):511-6. PubMed ID: 10380124
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo antitumoral activity of alkylphosphonates.
Ries UJ; Fleer EA; Breiser A; Unger C; Stekar J; Fenneberg K; Eibl H
Eur J Cancer; 1992; 29A(1):96-101. PubMed ID: 1445752
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of phosphatidylcholine synthesis is not the primary pathway in hexadecylphosphocholine-induced apoptosis.
van der Sanden MH; Houweling M; Duijsings D; Vaandrager AB; van Golde LM
Biochim Biophys Acta; 2004 Mar; 1636(2-3):99-107. PubMed ID: 15164757
[TBL] [Abstract][Full Text] [Related]
30. Investigations on the cellular uptake of hexadecylphosphocholine.
Fleer EA; Berkovic D; Eibl H; Unger C
Lipids; 1993 Aug; 28(8):731-6. PubMed ID: 8377589
[TBL] [Abstract][Full Text] [Related]
31. Cell-matrix interactions of normal and transformed human keratinocytes in vitro are modulated by the synthetic phospholipid analogue hexadecylphosphocholine.
Schön M; Schön MP; Geilen CC; Hoffmann M; Hakyi N; Orfanos CE; Reutter W
Br J Dermatol; 1996 Nov; 135(5):696-703. PubMed ID: 8977667
[TBL] [Abstract][Full Text] [Related]
32. Hexadecylphosphocholine inhibits phosphatidylcholine synthesis via both the methylation of phosphatidylethanolamine and CDP-choline pathways in HepG2 cells.
Jiménez-López JM; Carrasco MP; Segovia JL; Marco C
Int J Biochem Cell Biol; 2004 Jan; 36(1):153-61. PubMed ID: 14592540
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of phorbol-ester-stimulated phosphatidylcholine biosynthesis by the phospholipid analogue hexadecylphosphocholine.
Wieder T; Geilen CC; Reutter W
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):561-7. PubMed ID: 8387273
[TBL] [Abstract][Full Text] [Related]
34. Comparison of hexadecylphosphocholine with fish oil as an antitumor agent.
Colombo DT; Tran LK; Speck JJ; Reitz RC
J Lipid Mediat Cell Signal; 1997 Sep; 17(1):47-63. PubMed ID: 9302654
[TBL] [Abstract][Full Text] [Related]
35. Antiinvasive activity of hexadecylphosphocholine in vitro.
Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiproliferative activity of alkylphosphocholines.
Agresta M; D'Arrigo P; Fasoli E; Losi D; Pedrocchi-Fantoni G; Riva S; Servi S; Tessaro D
Chem Phys Lipids; 2003 Dec; 126(2):201-10. PubMed ID: 14623454
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomes.
Rysin A; Paal M; Lokerse WJM; Wedmann B; Hossann M; Vogeser M; Winter G; Lindner LH
Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183698. PubMed ID: 34283999
[TBL] [Abstract][Full Text] [Related]
38. Evidence for abrogation of oncogene-induced radioresistance of mammary cancer cells by hexadecylphosphocholine in vitro.
Bruyneel EA; Storme GA; Schallier DC; Van den Berge DL; Hilgard P; Mareel MM
Eur J Cancer; 1993; 29A(14):1958-63. PubMed ID: 8280489
[TBL] [Abstract][Full Text] [Related]
39. Cellular transport and lipid interactions of miltefosine.
Barratt G; Saint-Pierre-Chazalet M; Loiseau PM
Curr Drug Metab; 2009 Mar; 10(3):247-55. PubMed ID: 19442087
[TBL] [Abstract][Full Text] [Related]
40. Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
Kato Y; Ozawa S; Tsukuda M; Kubota E; Miyazaki K; St-Pierre Y; Hata R
FEBS J; 2007 Jun; 274(12):3171-83. PubMed ID: 17540003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
